Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sakurasaku Plus CoTSE:7097 +0.68%67 5-Year Yield-on-Cost % is 1.05 as of Aug. 04, 2026, which is 3% below its 10-year median of 1.08. GuruFocus rates TSE:7097 with a GF Score™ of 67/100 and a GF Value™ of 円1,216.43 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Sakurasaku Plus Co ranks worse than 78.26% on this metric.
Sakurasaku Plus Co's yield on cost for the quarter that ended in Jan. 2026 was 1.05.
The historical rank and industry rank for Sakurasaku Plus Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:7097'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.34 Med: 1.08 Max: 2.27
Current: 1.05
During the past 8 years, Sakurasaku Plus Co's highest Yield on Cost was 2.27. The lowest was 0.34. And the median was 1.08.
TSE:7097's 5-Year Yield-on-Cost % is ranked worse than 78.26% of 276
companies
in the Healthcare Providers & Services industry
Industry Median: 2.985
vs TSE:7097: 1.05
Sakurasaku Plus Co (TSE:7097) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Sakurasaku Plus Co 5-Year Yield-on-Cost % Related Terms
TSE:7097 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Sakurasaku Plus Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sakurasaku Plus Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sakurasaku Plus Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Sakurasaku Plus Co's 5-Year Yield-on-Cost % falls into.
Sakurasaku Plus Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Sakurasaku Plus Co (TSE:7097) has a 5-Year Yield-on-Cost % of 1.05 as of Aug. 04, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sakurasaku Plus Co and its competitors. This is near median its historical median of 1.08. Over the past decade, Sakurasaku Plus Co's 5-Year Yield-on-Cost % has ranged from 0.34 to 2.27. According to the industry distribution chart, Sakurasaku Plus Co ranks #216 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 78.3%.
Is Sakurasaku Plus Co's 5-Year Yield-on-Cost % too high?
Sakurasaku Plus Co's current 5-Year Yield-on-Cost % of 1.05 is near median its 10-year median of 1.08. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 2.27. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.99. Sakurasaku Plus Co's value of 1.05 is 64.8% below this industry median. Based on the distribution chart, Sakurasaku Plus Co ranks #216 out of 276 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Sakurasaku Plus Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sakurasaku Plus Co's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sakurasaku Plus Co ranks #216 out of 276 companies for 5-Year Yield-on-Cost %. This places Sakurasaku Plus Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.99. Sakurasaku Plus Co's value of 1.05 is 64.8% below this benchmark. Historically, Sakurasaku Plus Co's own 5-Year Yield-on-Cost % has ranged from 0.34 to 2.27 over the past decade. While the company's 10-year median is 1.08 vs. the industry median of 2.99, Sakurasaku Plus Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.99, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sakurasaku Plus Co's current 5-Year Yield-on-Cost % of 1.05 is 64.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sakurasaku Plus Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sakurasaku Plus Co's current 5-Year Yield-on-Cost % is 1.05, which is near median its own 10-year median of 1.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sakurasaku Plus Co stock overvalued right now?
Based on GuruFocus' analysis, Sakurasaku Plus Co (TSE:7097) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,216.43, compared to a current price of 円2,680.00 — trading 120.3% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.05, which is near median its 10-year median of 1.08 and 64.8% below the Healthcare Providers & Services industry median of 2.99. Sakurasaku Plus Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sakurasaku Plus Co (TSE:7097), the current 5-Year Yield-on-Cost % is 1.05 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sakurasaku Plus Co (TSE:7097) Overvalued in 2026?
Based on GuruFocus' analysis, Sakurasaku Plus Co stock appears to be overvalued.
The current stock price of 円2,680.00 is trading 120.3% above its estimated GF Value™ of 円1,216.43.
GuruFocus considers Sakurasaku Plus Co to be Significantly Overvalued.
Key valuation signals for TSE:7097:
5-Year Yield-on-Cost %: 1.05 (near median its 10-year median of 1.08)
GF Value™: 円1,216.43 vs. price of 円2,680.00 (120.3% above fair value)
Industry Position: 64.8% below the Healthcare Providers & Services median (#216 of 276)
No single metric tells the full story. See the TSE:7097 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sakurasaku Plus Co Ltd is engaged in the operation and use of childcare daycare centers. The company also provides real estate brokerage and management services. The Group operates in a single segment, the children and childcare support business.
67GF Score
Get the complete analysis for TSE:7097
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7097 has been successfully added to your 
